Wen-Bin Qian Selected Research

Wen-Bin Qian Research Topics

3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2018 - 12/2006
3	Leukemia 02/2018 - 01/2002
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 12/2016
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2020 - 12/2018
2	Multiple Myeloma 06/2013 - 10/2010
2	Neoplasms (Cancer) 09/2012 - 01/2007
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2022
1	Residual Neoplasm 12/2016
1	Hepatocellular Carcinoma (Hepatoma) 09/2012
1	Colonic Neoplasms (Colon Cancer) 08/2008
1	Hyperlipidemias (Hyperlipidemia) 08/2008
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2008
1	Melanoma (Melanoma, Malignant) 01/2007
1	Refractory Anemia with Excess of Blasts (RAEM) 08/2005

3	HomoharringtonineIBA 06/2013 - 07/2007
2	AclarubicinIBA 01/2020 - 01/2008
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 01/2008
2	Imatinib Mesylate (Gleevec)FDA Link 01/2015 - 12/2006
2	Arsenic Trioxide (Trisenox)FDA Link 06/2013 - 08/2005
1	sintilimabIBA 07/2022
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 07/2022
1	Chimeric Antigen ReceptorsIBA 07/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020
1	CGP 57380IBA 12/2018
1	Everolimus FDA Link 12/2018
1	TOR Serine-Threonine KinasesIBA 12/2018
1	SurvivinIBA 12/2018
1	Eukaryotic Initiation Factor-4EIBA 12/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2018
1	Beclin-1IBA 02/2018
1	Amino Acids FDA Link 09/2012
1	Antineoplastic Agents (Antineoplastics)IBA 09/2012
1	LigandsIBA 09/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2012
1	CaspasesIBA 09/2012
1	fludarabineIBA 10/2010
1	LipidsIBA 08/2008
1	AlkaloidsIBA 07/2007
1	InterleukinsIBA 01/2007
1	Telomerase (Telomerase Reverse Transcriptase)IBA 08/2005
1	Aligeron (AS 2)IBA 08/2005
1	Telomeric Repeat Binding Protein 1IBA 08/2005
1	ubenimexIBA 01/2002